Anúncio
Anúncio
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
3.93
USDPatrocinado
+0.08
+2.21%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
3.88
-0.05
-1.27%
Relatórios de Lucros MRVI
Rácio de surpresa positiva
MRVI separação 12 de 20 últimas estimativas.
60%
Próximo Relatório
Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$50.03M
/-$0.06
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+20.18%
/-25.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-11.54%
/--
Maravai LifeSciences Holdings, Inc. Class A Common Stock earnings per share and revenue
On 06 de nov. de 2025, MRVI reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 3.96% surprise. Revenue reached 41.63 milhão, compared to an expected 49.98 milhão, with a -16.71% difference. The market reacted with a -0.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.06 USD, with revenue projected to reach 50.03 milhão USD, implying an diminuir of -25.00% EPS, and aumentar of 20.18% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
FAQ
What were Maravai LifeSciences Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Maravai LifeSciences Holdings, Inc. Class A Common Stock reported EPS of -$0.08, beating estimates by 3.96%, and revenue of $41.63M, -16.71% below expectations.
How did the market react to Maravai LifeSciences Holdings, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -0.69%, changed from $2.89 before the earnings release to $2.87 the day after.
When is Maravai LifeSciences Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for Maravai LifeSciences Holdings, Inc. Class A Common Stock's next earnings report?
Based on 12
analistas, Maravai LifeSciences Holdings, Inc. Class A Common Stock is expected to report EPS of -$0.06 and revenue of $50.03M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio